Newborn Screening – What’s good to know?
What does newborn screening mean?
Newborn screening for congenital metabolic and hormonal disorders is a very successful preventive measure in childhood. Newborns have been screened for phenylketonuria since the 1960s, and for hypothyroidism and galactosaemia since the 1980s. In 2004, screening was extended to twelve target diseases. It was then expanded to include cystic fibrosis from 2016 and tyrosinaemia type I in 2018. Recently, severe combined immunodeficiencies were added in 2019.
Around one in every 1,000 children is diagnosed with one of the diseases described above. If undetected, these diseases can lead to life-threatening metabolic crises, organ damage, physical or mental disabilities, or even death. Newborn screening allows for immediate, targeted treatment as soon as…
Dann nutzen Sie jetzt unser Probe-Abonnement mit 3 Ausgaben zum Kennenlernpreis von € 19,90.
Jetzt Abonnent werden